TissGeneSummary for PAGE4 |
Gene summary |
Basic gene information | Gene symbol | PAGE4 |
Gene name | P antigen family, member 4 (prostate associated) | |
Synonyms | CT16.7|GAGE-9|GAGEC1|JM-27|PAGE-1|PAGE-4 | |
Cytomap | UCSC genome browser: Xp11.23 | |
Type of gene | protein-coding | |
RefGenes | NM_007003.3, | |
Description | P antigen family member 4g antigen family C member 1prostate-associated gene protein 4 | |
Modification date | 20141207 | |
dbXrefs | MIM : 300287 | |
HGNC : HGNC | ||
Ensembl : ENSG00000101951 | ||
HPRD : 02239 | ||
Vega : OTTHUMG00000024155 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PAGE4 | |
BioGPS: 9506 | ||
Pathway | NCI Pathway Interaction Database: PAGE4 | |
KEGG: PAGE4 | ||
REACTOME: PAGE4 | ||
Pathway Commons: PAGE4 | ||
Context | iHOP: PAGE4 | |
ligand binding site mutation search in PubMed: PAGE4 | ||
UCL Cancer Institute: PAGE4 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Prostate | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | PRAD | |
Reference showing the relevant tissue of PAGE4 | ||
Description by TissGene annotations | Protective TissGene in OS Protective TissGene in RFS Significant down-regulated DEG TissgsKTS CNV lost TissGeneKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for PAGE4 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRC | -1.830730909 | -0.791682297 | -1.039048611 | 5.27E-10 | 1.76E-09 |
KICH | -1.691943964 | -0.558235964 | -1.133708 | 0.00128 | 0.002720463 |
LIHC | 0.717026036 | -1.406613964 | 2.12364 | 0.000139 | 0.000464938 |
KIRP | -1.861542714 | -0.784689589 | -1.076853125 | 0.000119 | 0.000396431 |
PRAD | 5.026716421 | 6.374141421 | -1.347425 | 5.77E-05 | 0.000256559 |
Top |
TissGene-miRNA for PAGE4 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for PAGE4 |
TissGeneSNV for PAGE4 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.P86L | SKCM | 2 |
p.E55K | UCEC | 2 |
p.P89L | HNSC | 1 |
p.C63F | CESC | 1 |
p.P44L | UCEC | 1 |
p.R72Q | SKCM | 1 |
p.D99N | SKCM | 1 |
p.G78C | HNSC | 1 |
p.A92V | BLCA | 1 |
p.K70N | BLCA | 1 |
p.V59I | KIRC | 1 |
p.R6I | UCEC | 1 |
p.P86A | LUAD | 1 |
p.P87T | LUAD | 1 |
p.D67H | STAD | 1 |
Top |
TissGeneCNV for PAGE4 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for PAGE4 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
TCGAfusionPortal | PRADA | BRCA | TCGA-A2-A04U-01A | PSD3-PAGE4 | CDS-5UTR | Chr8:18871073 | ChrX:49595002 |
Top |
TissGeneNet for PAGE4 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for PAGE4 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for PAGE4 |
TissGeneDrug for PAGE4 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for PAGE4 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
umls:C0025202 | melanoma | 1 | BeFree |
umls:C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
umls:C0038356 | Stomach Neoplasms | 1 | LHGDN |
umls:C0205851 | Germ cell tumor | 1 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 1 | BeFree |
umls:C0494165 | Secondary malignant neoplasm of liver | 1 | BeFree |
umls:C0600139 | Prostate carcinoma | 1 | BeFree |
umls:C1527249 | Colorectal Cancer | 1 | BeFree |
umls:C1704272 | Benign Prostatic Hyperplasia | 1 | BeFree |